YVETTE SCHARF: Open Payments
NPI 1417474164 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 33 payments from 14 companies in 2025. Trend: 2023 $840 · 2024 $773 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $188 |
| Amgen Inc. | 4 | $169 |
| Axsome Therapeutics, Inc. | 4 | $101 |
| Viatris Specialty LLC | 4 | $67 |
| ABBVIE INC. | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| ACADIA Pharmaceuticals Inc | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
Products named: REPATHA, Auvelity, YUPELRI, Rybelsus, QULIPTA, Ozempic, OTEZLA, REXULTI.
Industry payments across MI — which companies pay providers there.
